☆ 4.7 Article

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

DIABETES OBESITY & METABOLISM (2022)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β-cell dysfunction

Nathalie Esser et al.

Summary: The neprilysin inhibitor sacubitril improves glycemic status in a mouse model of reduced insulin secretion. Sacubitril enhances insulin secretion in response to intravenous glucose, but not oral glucose. The increased glucose-mediated insulin secretion is dependent on GLP-1 receptor.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism

Sasha A. S. Kjeldsen et al.

Summary: Inhibitors of the protease neprilysin have been found to increase glucagon levels, leading to enhanced postprandial amino acid metabolism without affecting glycemia.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials

Francesco Spannella et al.

ESC HEART FAILURE (2020)

Add to Collection

Review Endocrinology & Metabolism

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control

Jelena P. Seferovic et al.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure

Milton Packer

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Add to Collection

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

Related references

Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β-cell dysfunction

Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism

Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control

Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

Export Citation

Share Paper